Asthma biologics can be continued and initiated during conception, throughout pregnancy and while breastfeeding, especially ...

Regeneron's lead counsel was Jonathan D. Polkes of White & Case LLP.

Dupixent is a prescription medication used to treat various conditions, including allergic rhinitis, asthma, and atopic ...

The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...

Detailed price information for Atlas Energy Solutions Inc Cl A (AESI-N) from The Globe and Mail including charting and trades ...

Slow progress, pipeline uncertainty & lack of catalysts weigh despite strong cash. Click to read why KYMR stock is a Hold.

Sanofi said it will invest at least $20 billion in the US through 2030, joining other pharmaceutical companies boosting their ...

FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial shows significant symptom reduction ...

Dymax, a leading manufacturer of rapid light-curing materials and equipment, responds to market interest in sustainable adhesive solutions and changing regulatory requirements by expanding its ...

The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by ...

We came across a bullish thesis on Sanofi (SNY) on Substack by Business Model Mastery. In this article, we will summarize the ...